Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

THYROCARE TECHNOLOGIES vs DR. LAL PATHLABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    THYROCARE TECHNOLOGIES DR. LAL PATHLABS THYROCARE TECHNOLOGIES/
DR. LAL PATHLABS
 
P/E (TTM) x 35.9 71.4 50.2% View Chart
P/BV x 14.3 24.4 58.6% View Chart
Dividend Yield % 2.2 0.6 384.2%  

Financials

 THYROCARE TECHNOLOGIES   DR. LAL PATHLABS
EQUITY SHARE DATA
    THYROCARE TECHNOLOGIES
Mar-21
DR. LAL PATHLABS
Mar-21
THYROCARE TECHNOLOGIES/
DR. LAL PATHLABS
5-Yr Chart
Click to enlarge
High Rs1,2122,735 44.3%   
Low Rs4851,305 37.2%   
Sales per share (Unadj.) Rs93.6189.7 49.3%  
Earnings per share (Unadj.) Rs21.435.6 60.2%  
Cash flow per share (Unadj.) Rs27.144.8 60.5%  
Dividends per share (Unadj.) Rs25.0020.00 125.0%  
Avg Dividend yield %2.91.0 297.5%  
Book value per share (Unadj.) Rs80.3144.6 55.5%  
Shares outstanding (eoy) m52.8783.34 63.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x9.110.6 85.2%   
Avg P/E ratio x39.656.8 69.8%  
P/CF ratio (eoy) x31.345.1 69.4%  
Price / Book Value ratio x10.614.0 75.7%  
Dividend payout %116.756.2 207.6%   
Avg Mkt Cap Rs m44,869168,365 26.7%   
No. of employees `000NANA-   
Total wages/salary Rs m5812,737 21.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,94615,813 31.3%  
Other income Rs m124513 24.2%   
Total revenues Rs m5,07116,326 31.1%   
Gross profit Rs m1,7134,363 39.3%  
Depreciation Rs m303772 39.2%   
Interest Rs m9160 5.4%   
Profit before tax Rs m1,5253,944 38.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m393979 40.2%   
Profit after tax Rs m1,1322,965 38.2%  
Gross profit margin %34.627.6 125.5%  
Effective tax rate %25.824.8 103.8%   
Net profit margin %22.918.7 122.1%  
BALANCE SHEET DATA
Current assets Rs m2,38111,452 20.8%   
Current liabilities Rs m9512,743 34.7%   
Net working cap to sales %28.955.1 52.5%  
Current ratio x2.54.2 60.0%  
Inventory Days Days10721 512.5%  
Debtors Days Days3315 214.1%  
Net fixed assets Rs m3,0204,881 61.9%   
Share capital Rs m529833 63.4%   
"Free" reserves Rs m3,71511,219 33.1%   
Net worth Rs m4,24312,053 35.2%   
Long term debt Rs m01 0.0%   
Total assets Rs m5,40216,333 33.1%  
Interest coverage x176.325.6 687.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.91.0 94.6%   
Return on assets %21.119.1 110.4%  
Return on equity %26.724.6 108.5%  
Return on capital %36.234.0 106.2%  
Exports to sales %00-   
Imports to sales %0.70.7 101.4%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m33105 31.7%   
Fx inflow Rs m52143 36.1%   
Fx outflow Rs m33105 31.7%   
Net fx Rs m1838 48.3%   
CASH FLOW
From Operations Rs m1,1603,982 29.1%  
From Investments Rs m-502-2,120 23.7%  
From Financial Activity Rs m-616-1,386 44.4%  
Net Cashflow Rs m42476 8.9%  

Share Holding

Indian Promoters % 71.2 55.2 129.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.7 32.6 57.4%  
FIIs % 12.1 26.8 45.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.8 44.8 64.3%  
Shareholders   62,936 125,953 50.0%  
Pledged promoter(s) holding % 100.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare THYROCARE TECHNOLOGIES With:   TEJNAKSH HEALTHCARE  N.G.IND.LTD.  LOTUS EYE CARE  ASPIRA PATHLAB & DIAGNOSTICS   NARAYANA HRUDAYALAYA  



Today's Market

Sensex Down 400 Points, Nifty Below 18,100; Adani Ports & Titan Among Top Losers(10:30 am)

Asian share markets are lower today, extending falls on Wall Street as investors awaited a monetary policy decision from the Bank of Japan and European Central Bank (ECB) later in the day.

Related Views on News

THYROCARE TECHNOLOGIES 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of THYROCARE TECHNOLOGIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of THYROCARE TECHNOLOGIES. Also includes updates on the valuation of THYROCARE TECHNOLOGIES.

DR. LAL PATHLABS 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DR. LAL PATHLABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DR. LAL PATHLABS. Also includes updates on the valuation of DR. LAL PATHLABS.

DR. LAL PATHLABS Announces Quarterly Results (1QFY22); Net Profit Up 370.8% (Quarterly Result Update)

Aug 3, 2021 | Updated on Aug 3, 2021

For the quarter ended June 2021, DR. LAL PATHLABS has posted a net profit of Rs 1 bn (up 370.8% YoY). Sales on the other hand came in at Rs 6 bn (up 128.0% YoY). Read on for a complete analysis of DR. LAL PATHLABS's quarterly results.

More Views on News

Most Popular

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

Up 31,500% in a Year! This Packaging Company Sheds its Penny Stock Status(Views On News)

Oct 18, 2021

What's driving the relentless rally in this packaging company?

Insider Alert! Promoters are Increasing their Stakes in these 5 Companies(Views On News)

Oct 19, 2021

Promoters of many small and mid-cap companies are raising their stakes since the last few quarters.

The One Company Riding the Auto Revolution Beyond EVs(Profit Hunter)

Oct 22, 2021

It's not just about batteries taking over the internal combustion engine. Bigger disruptive forces are coming along with electrification.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

THYROCARE TECHNOLOGIES SHARE PRICE


Oct 28, 2021 10:37 AM

TRACK THYROCARE TECHNOLOGIES

  • Track your investment in THYROCARE TECHNOLOGIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON THYROCARE TECHNOLOGIES

THYROCARE TECHNOLOGIES 8-QTR ANALYSIS

COMPARE THYROCARE TECHNOLOGIES WITH

MARKET STATS